The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
Hess Midstream LP
HESM · the NYSE · USD · Market cap $6.3B
Hess Midstream LP acquires, owns, operates, and develops midstream assets and provide fee-based services to sponsor, its subsidiaries, and third-party customers in the United States.
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price30.54 USD at the 18 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 18 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 1.35)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $24.60 to $28.29, base estimate $24.60 (screen dated 2026-11-18).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.35, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Hess Midstream LP holds its Markup at $30.54. The statistical read favours the sellers, held for 29 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 29 days |
| Price at the screen | $30.54 |
| Valuation | 10.43 trailing · 10.99 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.65 |
Five Screens: HESM's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 85.96% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 3.47% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Hess Midstream LP's business is in a permissible area, but its interest-bearing debt is about 86% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HESM's ethical verdict changes
Today HESM does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 18 Nov 2026: it trades above our $24.60 fair value estimate.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. The price runs 24.1% above the base estimate.
Third-party analyst targets: 7 covering, consensus Underperform. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $24.60, with a range of $24.60 to $28.29, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsOil pipes promise steady fees yet trap value
Picture the steady flow of crude from wellhead to export terminal. Hess Midstream collects fees for moving and storing that oil, yet the business sits inside an industry where volumes and prices swing with global demand. Revenue growth sits at just 2 percent and the shares trade above our fair value, leaving no margin of safety at the current price.
The forward multiple of 13.3 times earnings looks modest next to a 23 percent profit margin and 153 percent return on equity. Those figures reflect the fee-based model and high leverage, but they also sit at a point in the cycle where earnings may already be near peak. Analyst consensus calls the stock underperform with a median target below the current quote, and growth remains modest.
The real risk is the classic cyclical trap. A low multiple on elevated earnings can signal the top of the cycle rather than a bargain, and any drop in drilling activity would quickly cut volumes. Currency and commodity exposure add further volatility even though the ethical screen is clear. Analysis, not advice.
| Forward P/E | 11.0xreasonably valued |
| Trailing P/E | 10.4xreasonably valued |
| EPS, trailing | 2.92 |
| EPS, forward | 2.77 |
| Revenue growth | -2.6%revenue is shrinking |
| Profit margin | 23.5%healthy profit margins |
| Return on equity | 163.3%an exceptional return on shareholder capital |
| FCF yield | 8.79% |
| Dividend yield | 7.92% |
| Debt to equity | 8.90heavy leverage: higher risk if revenue softens |
| Current ratio | 0.25below 1: short-term bills exceed liquid assets |
| Beta | 0.65steadier than the market |
| Short interest, float | 0.18% |
| 52-week range | 29.52 - 41.44 |
| Market cap | $6.3B |
HESM-specific watchpoints · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37. Since the last review it its composite score eased.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 18.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Hess Midstream (HESM) Earnings Put Fair Value Back In Focus Yahoo Finance · 10d ago
- Chevron’s Refineries Ran at 98%. Its January Report Must Absorb a $4 Billion Hess Charge Yahoo Finance · 12d ago
- Here's What Key Metrics Tell Us About Hess Midstream Partners (HESM) Q3 Earnings Yahoo Finance · 21d ago
- Hess Midstream LP Reports Estimated Results for the Third Quarter of 2026 Yahoo Finance · 21d ago
- The Events That Matter Most For Chevron Stock Yahoo Finance · 24d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $39.19 | +0.1% | · | $1,001 | +0.1% |
| 2 months | $38.76 | +1.2% | $0.78 | $1,032 | +3.2% |
| 3 months | $38.13 | +2.8% | $0.78 | $1,049 | +4.9% |
| 6 months | $33.03 | +18.7% | $1.54 | $1,234 | +23.4% |
| 1 year | $35.73 | +9.7% | $3.04 | $1,182 | +18.2% |
| 2 years | $29.93 | +31.0% | $5.80 | $1,504 | +50.4% |
| 3 years | $22.76 | +72.2% | $8.30 | $2,087 | +108.7% |
| 5 years | $17.65 | +122.1% | $12.66 | $2,938 | +193.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HESM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.